Seminars in Nuclear Medicine
Volume 38, Issue 5 , Pages 335-346 , September 2008

Kinetic Modeling in Support of Radionuclide Dose Assessment

  • Paolo Vicini, PhD

      Affiliations

    • Resource Facility for Population Kinetics, Department of Bioengineering, University of Washington, Seattle, WA.
    • Corresponding Author InformationAddress reprint requests to Paolo Vicini, Resource Facility for Population Kinetics, Department of Bioengineering, Box 355061, University of Washington, Seattle, WA 98195-4290.
    • ,
  • A. Bertrand Brill, MD, PhD

      Affiliations

    • Department of Radiology and Radiological Sciences, Vanderbilt University, Nashville, TN.
    • ,
  • Michael G. Stabin, PhD, CHP

      Affiliations

    • Department of Radiology and Radiological Sciences, Vanderbilt University, Nashville, TN.
    • ,
  • Aldo Rescigno, PhD

      Affiliations

    • Stillwater, MN.

References 

  1. ICRP. International Commission on Radiological Protection: History, Policies, Procedures. Oxford: Elsevier Science Ltd; 1998;
  2. Luigi Bertelli (Vamba): Il Giornalino di Gian Burrasca. Firenze, Bemporad, 1912
  3. Chievitz O, Hevesy G. The first radioindicator study in the life sciences with a man-made radionuclide. Nature. 1935;136:754–755Reprinted in J Nucl Med 16:1107-1108, 1976 [Commentary by W.G. Myers]
  4. Cobelli C, Foster D, Toffolo G. Tracer Kinetics in Biomedical Research: From Data to Model. San Diego: Kluwer Academic/Plenum Publishers; 2000;
  5. Rowland M, Balant L, Peck C. Physiologically based pharmacokinetics in drug development and regulatory science: A workshop report (Georgetown University, Washington, DC, May 29-30, 2002). AAPS Pharm Sci. 2004;6:E6
  6. Stabin MG, Brill AB. State of the art in nuclear medicine dose assessment. Semin Nucl Med. 2008;38:308–320
  7. Berman M: Kinetic models for absorbed dose calculations. MIRD Pamphlet No. 12, Society of Nuclear Medicine, Jan. 1977
  8. Akaike H. A new look at the statistical model identification. IEEE Trans Automatic Control. 1974;19:716–723
  9. Schwarz G. Estimating the dimension of a model. Ann Stat. 1978;6:461–464
  10. Rescigno A. The rise and fall of compartmental analysis. Pharmacol Res. 2001;44:337–342
  11. Becquerel H. Sur les radiations émises par phosphorescence. Comptes Rendus de l'Académie des Sciences (Paris). 1896;122:420–421
  12. Becquerel H. Sur les Radiations Invisibles Émises par les Corps Phosphorescents. Comptes Rendus Acad Scis (Paris). 1896;122:501–503
  13. Rutherford E, Soddy BA. The cause and nature of radioactivity. Philosophical Magazine. 1902;4:370
  14. Rutherford E. The succession of changes in radioactive bodies. R Soc Lond Phil Trans. 1904;204:169
  15. Behnke AR, Thomson RM, Shaw LA. The rate of elimination of dissolved nitrogen in man in relation to the fat and water content of the body. Am J Physiol. 1935;114:137–146
  16. Teorell T. Kinetics of distribution of substances administered to the body (I: The extravascular modes of administration). Arch Int Pharmacodyn Thér. 1937;57:205–225
  17. Teorell T. Kinetics of distribution of substances sdministered to the body (II: The Intravascular Modes of Administration). Arch Int Pharmacodyn Thér. 1937;57:226–240
  18. DiStefano JJ, Landaw EM. Multiexponential, multicompartmental, and noncompartmental modeling (I: Methodological limitations and physiological interpretations). Am J Physiol. 1984;246:R651–R664
  19. Artom C, Sarzana G, Segré E. Influence des grasses alimentaires sur la formation des phospholipides dans les tissues animaux (nouvelles recherches). Arch Int Physiol. 1938;47:245–276
  20. Goresky CA. A linear method for determining liver sinusoidal and extravascular volumes. Am J Physiol. 1963;204:626–640
  21. Sheppard CW. The theory of the study of transfers within a multi-compartment system using isotopic tracers. J Appl Phys. 1948;19:70–76
  22. Sheppard CW, Householder AS. The mathematical basis of the interpretation of tracer experiments in closed steady-state systems. J Appl Phys. 1951;22:510–520
  23. Rescigno A, Segre G. La Cinetica dei Farmaci e dei Traccianti Radioattivi. Torino: Boringhieri; 1961;
  24. Hearon JZ. Theorems on Linear Systems. Ann N Y Acad Sci. 1963;108:36–68
  25. Brownell GL, Berman M, Robertson JS. Nomenclature for tracer kinetics. Int J Appl Rad Isot. 1968;19:249–262
  26. Iodine kineticsBerman M. Methods of investigative and diagnostic endocrinology. Amsterdam: North-Holland Publishing Co; 1972;
  27. Rescigno A, Beck JS. Compartments. In:  Rosen R editors. Foundations of Mathematical Biology. Volume 2. New York: Academic Press; 1972;p. 255–322
  28. Jacquez JA. Compartmental Analysis in Biology and Medicine. Amsterdan: Elsevier; 1972;
  29. Gurpide E. Tracer Methods in Hormone Research. New York: Springer-Verlag; 1975;
  30. siri W. Isotopic tracers and nuclear radiations with applications to biology and medicine, in Theor of Tracer Methods. New York: McGraw-Hill; 1949;
  31. Schmidt KC, Turkheimer FE. Kinetic modeling in positron emission tomography. Q J Nucl Med. 2002;46:70–85
  32. Bertoldo A, Vicini P, Sambuceti G, et al. Evaluation of compartmental and spectral analysis models of [18F]FDG kinetics for heart and brain studies with PET. IEEE Trans Biomed Eng. 1998;45:1429–1448
  33. Rescigno A, Beck JS. Compartments. In:  Rosen R editors. Foundations of Mathematical Biology, Volume II: Cellular Systems. New York: Academic Press, pp 255-322; 1972;
  34. Bergner PEE. The significance of certain kinetic methods, especially with respect to the tracer dynamic definition of metabolic turnover. Acta Radiol Suppl. 1962;210:1–59
  35. Zierler K. A critique of compartmental analysis. Ann Rev Biophys Bioeng. 1981;10:531–562
  36. Rescigno A, Beck JS. The use and abuse of models. J Pharmacokin Biopharm. 1987;15:327–340
  37. Rescigno A. On the use of pharmacokinetic models. Phys Med Biol. 2004;49:4657–4676
  38. Rescigno A. Clearance, turnover time, and volume of distribution. Pharmacol Res. 1997;35:189–193
  39. Robertson JS. Theory and use of tracers in determining transfer rates in biological systems. Physiol Rev. 1957;37:133–154
  40. Berman M. Iodine kinetics in man—a model. J Clin Endocrin Metab. 1968;28:1–14
  41. Berkovski V, Eckerman KF, Phipps AW, et al. Dosimetry of radioiodine for embryo and fetus. Radiat Prot Dosimetry. 2003;105:265–268
  42. Berman M. The formulation and testing of models. Ann NY Acad Sci. 1963;108:182–194
  43. Berman M, Weiss MF, Shahn E. Some formal approaches to the analysis of kinetic data in terms of linear compartment systems. Biophys J. 1962;2:289–316
  44. Berman M, Schoenfeld R. Invariants in experimental data on linear kinetics and the formulation of models. J Appl Phys. 1956;27:1361–1370
  45. DiStefano JJ. Noncompartmental vs. compartmental analysis: Some bases for choice. Am J Physiol. 1982;243:R1–R6
  46. DiStefano JJ. Concepts, properties, measurements, and computation of clearance rates of hormones and other substances in biological systems. Ann Biomed Eng. 1976;4:302–319
  47. Oddie TH. Analysis of radio-iodine uptake and excretion curves. Br J Radiol. 1949;257:261–267
  48. Johansson L, Leide-Svegborn S, Mattsson S, et al. Biokinetics of iodide in man: Refinement of current ICRP dosimetry models. Cancer Biother Radiopharma. 2003;18:445–450
  49. Berkovski V. New iodine models family for simulation of short-term biokinetics processes, pregnancy and lactation. Food Nutr Bull. 2002;23:87–94(suppl)
  50. Robertson JS, Price RR, Budinger TF, et al. MIRD Report No. 11 (Iron-52, Fe-55, and Iron-59 used to study ferrokinetics). J Nucl Med. 1983;24:339–348
  51. International Commission on Radiation Units and Measurements (ICRU). Absorbed-Dose Specification in Nuclear Medicine. ICRU-Report 67. Bethesda, MD: ICRU; 2002;
  52. Boston RC, Greif PC, Berman M. Conversational SAAM—an interactive program for kinetic analysis of biological systems. Comput Programs Biomed. 1981;13:111–119
  53. Greif P, Wastney M, Linares O, et al. Balancing needs, efficiency, and functionality in the provision of modeling software: A perspective of the NIH WinSAAM Project. Adv Exp Med Biol. 1998;445:3–20
  54. Barrett PH, Bell BM, Cobelli C, et al. SAAM II: Simulation, analysis, and modeling software for tracer and pharmacokinetic studies. Metabolism. 1998;47:484–492
  55. Bass L, Aisbett J, Bracken AJ. Asymptotic forms of tracer clearance curves: Theory and applications of improved extrapolations. J Theoret Biol. 1984;111:755–785
  56. Pharmakinetic software. http://www.boomer.org/pkin/soft.htmlAccessed May 21, 2008
  57. Cobelli C, Caumo A. Using what is accessible to measure that which is not: Necessity of model of system. Metabolism. 1998;47:1009–1035
  58. Cobelli C, DiStefano JJ. Parameter and structural identifiability concepts and ambiguities: A critical review and analysis. Am J Physiol. 1980;239:R7–R24
  59. Landaw EM, DiStefano JJ. Multiexponential, multicompartmental, and noncompartmental modeling (II: Data analysis and statistical considerations). Am J Physiol. 1984;246:R665–R677
  60. Sheiner LB, Beal SL. Pharmacokinetic parameter estimates from several least squares procedures: Superiority of extended least squares. J Pharmacokin Biopharm. 1985;13:185–201
  61. Spilker ME, Vicini P. An evaluation of extended vs weighted least squares for parameter estimation in physiological modeling. J Biomed Inform. 2001;34:348–364
  62. Muzic RF, Christian BT. Evaluation of objective functions for estimation of kinetic parameters. Med Phys. 2006;33:342–353
  63. D'Argenio DZ. Optimal sampling times for pharmacokinetic experiments. J Pharmacokin Biopharm. 1981;9:739–756
  64. Siegel JA, Thomas SR, Stubbs JB, et al. MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates. J Nucl Med. 1999;40:37S–61S
  65. Beal SL, Sheiner LB. Estimating population kinetics. Crit Rev Biomed Eng. 1982;8:195–222
  66. Sheiner LB, Beal SL. Evaluation of methods for estimating population pharmacokinetic parameters. III: Monoexponential model: Routine clinical pharmacokinetic data J Pharmacokin Biopharm. 1983;11:303–319
  67. Cloutier R, Smith S, Watson E, et al. Dose to the fetus from radionuclides in the bladder. Health Phys. 1973;25:147–161
  68. Eve IS. A review of the physiology of the gastrointestinal tract in relation to radiation doses from radioactive material. Health Phys. 1966;12:131–161
  69. International Commission on Radiological Protection. Limits for Intakes of Radionuclides by Workers. ICRP Publication 30. New York: Pergamon Press; 1979;
  70. ICRP Publication 100 Human Alimentary Tract Model for Radiological Protection. Volume 35, Issue 4. ICRP Press, 2005, pp 1-142
  71. ICRP Publication 89: Basic Anatomical And Physiological Data for Use in Radiological Protection: Reference Values, ICRP Press, 2003
  72. Stabin MG, Eckerman KF, Bolch WE, et al. Evolution and status of bone and marrow dose models. Cancer Biother Radiopharm. 2002;17:427–434
  73. Sgouros G, Stabin M, Erdi Y, et al. Red marrow dosimetry for radiolabeled antibodies that bind to marrow, bone or blood components. Med Phys. 2000;27:2150–2164
  74. Sgouros G. Bone marrow dosimetry for radioimmunotherapy; Theoretical consideration. J Nucl Med. 1993;34:689–694
  75. Cremonesi M, Ferrari M, Bodei L, et al. Dosimetry in peptide radionuclide receptor therapy: A review. J Nucl Med. 2006;47:1467–1475

PII: S0001-2998(08)00074-3

doi: 10.1053/j.semnuclmed.2008.05.007

Seminars in Nuclear Medicine
Volume 38, Issue 5 , Pages 335-346 , September 2008

Article Tools

* Image Usage & Resolution